Stockholders' Equity - Schedule of Activity Under The Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2026	Dec. 31, 2025
Stockholders' Equity Note [Abstract]
Balance at beginning of period	4,135,501
Options granted	83,025
Options exercised	(232,777)
Options forfeited	(50,649)
Balance at end of period	3,935,100	4,135,501
Options vested and expected to vest as of end of period	3,935,100
Options exercisable at end of period	2,460,544
Balance at beginning of period	$ 8.7
Options granted , Weighted average exercise price	22.02
Options exercised, Weighted average exercise price	4.66
Options forfeited , Weighted average exercise price	10.18
Balance at end of period	9.24	$ 8.7
Weighted-average exercise price, Options vested and expected to vest at end of period	9.24
Weighted-average exercise price, Options exercisable at end of period	$ 6.74
Weighted-average remaining contractual life in years	7 years 3 months 14 days	7 years 4 months 17 days
Weighted-average remaining contractual life in years, Options vested, and expected to vest	7 years 3 months 14 days
Weighted-average remaining contractual life in years, Options exercisable at end of period	6 years 8 months 1 day
Aggregate intrinsic value	$ 36,509	$ 54,842
Aggregate intrinsic value, Options vested and expected to vest at end of period	36,509
Aggregate intrinsic value, Options exercisable at end of period	$ 28,651

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.